Format

Send to

Choose Destination
Clin Infect Dis. 2013 Oct;57(7):1001-4. doi: 10.1093/cid/cit393. Epub 2013 Jun 11.

The serum galactomannan index predicts mortality in hematopoietic stem cell transplant recipients with invasive aspergillosis.

Author information

1
Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center.

Abstract

We examined the relationship between serum and bronchoalveolar lavage (BAL) galactomannan index (GMI) values and mortality in allogeneic hematopoietic cell transplant recipients with invasive pulmonary aspergillosis. Using a clinical sign and symptom-initiated approach, we found that the serum but not the BAL GMI level correlated with 42- and 180-day patient mortality.

KEYWORDS:

Aspergillus; aspergillosis; galactomannan; mortality; transplant

PMID:
23759343
PMCID:
PMC3765008
DOI:
10.1093/cid/cit393
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Silverchair Information Systems Icon for PubMed Central
Loading ...
Support Center